Dr. Anthony Fauci said Thursday that he believes federal regulators will allow a coronavirus vaccine to be distributed this fall only if it’s based on science and “hard data,” a sharp veer from President Donald Trump’s own rosy predictions about the vaccine and his administration’s efforts to speed up development before the election.
They are going to have to release ALL of the data and have it peer reviewed before I believe any of it. Fauci may say it, but it’s obvious he’s not in charge of decision making.
FDA…DSMBoard…are “very, very committed to making sure that science prevails and not politics,” Fauci said.
Thank you for trying to speak up for the dedicated civil servants/healtcare staff who are doing their jobs regardless of political pressures and beliefs like you Dr. Fauci, and for trying to calm fears on faulty vaccines.
While I will believe in you, I will think twice or more on what this mendacious administration will tell us because they have gaslighting and 20K lying priors!
The though of Trump’s rushed vaccine combined with Russia…does not seem like a good idea!
And in this instance, I’d gladly say “Trump First”!
The NIH for which Fauci works has no authority or role in approving the vaccine. You cannot trust the COVID-19 task force, the HHS, CDC or the FDA. They are all political hacks working for Trump’s re-election.
On a side note, Russia’s vaccine appears to be safe and effective in small trials so far. True, only 76 people and only half were given the vaccine and they were all young. They started a new trial with 40,000 this week.
Sounds like they are rolling it nationwide soon, regardless.
If it traded o the NY stock exchange, the stock would most likely double.
I have to admit, irrespective of Fauci’s reassurances, that I’m still skeptical enough to be concerned with Trump’s getting a supply from Uncle Vlad. The Russians eschewed phase iii trial for their vaccine and are administering it to selected members of their public as we speak. The Astra Zeneca trials in FL were suspended on the apparent reason that the government would consider successful phase iii trials in other countries as being sufficient to proceed.
The most likely outcome is that the FDA will issue an emergency use authorization for one or more of the leading vaccine candidates based on production of antibodies. There is just insufficient time to demonstrate efficacy before November 1. The problems, or course, are 1) antibodies to the spike protein may not be protective, 2) the vaccine(s) may not raise antibodies in the most susceptible age or demographic groups, and 3) only immediate adverse events will be detected. Longer term adverse events or those that occur at lower frequency will not be detected. None-the-less, the FDA will likely do this while adding the caveat that this step does not constitute “approval.” The long term consequences could be profound, not just in loss of public confidence, but if the vaccine does not provide protection (or just marginal protection) it could compromise use of any subsequent vaccine that might be efficacious.
I wouldn’t either but…The trials were monitored by The Lancet:
The trials covered in The Lancet study were phase 1 and 2, which involve smaller numbers of participants and aim to establish whether a drug works, if there any side effects or safety concerns, and appropriate dosage levels.
If Trump wants a vaccine released before the election he’ll run over Fauci, Birx, the FDA, the NIH, the AMA and everyone else like a truck plowing down a deer on the highway.